Literature DB >> 16703400

Metabolic correlates of toluene abuse: decline and recovery of function in adolescent animals.

Wynne K Schiffer1, Dianne E Lee, David L Alexoff, Rich Ferrieri, Jonathan D Brodie, Stephen L Dewey.   

Abstract

RATIONALE: Children and adolescents will readily abuse household products that contain solvents such as toluene. It is likely that reinforcing exposures to toluene alter brain glucose metabolism.
OBJECTIVE: Using an animal model of drug reinforcement, we sought to identify a metabolic signature of toluene abuse in the adolescent rodent brain. Small animal PET (microPET), in combination with the glucose analog radiotracer, (18)FDG, were used to evaluate the metabolic consequences of inhaled toluene.
METHODS: The exposure protocol paralleled our previously established method for assessing the conditioned reinforcing effects of toluene (5,000 ppm) using the conditioned place preference (CPP) paradigm. Animals were scanned at baseline and 2 h after the last exposure. Follow-up (18)FDG scans occurred 1 day, 3 weeks, and 2 months later.
RESULTS: After six pairings, 38% of the animals preferred the toluene paired chamber and 25% were averse. The immediate metabolic effect in toluene-exposed animals was a 20% decline in whole brain (18)FDG uptake. Twenty-four hours following the last exposure, the whole brain decline was 40%, and 2 months later, the decline was 30% of pretoluene levels. A region-by-region analysis demonstrated significant additional decreases in the pons, cerebellum, striatum, midbrain, temporal cortex, and hippocampus. Two months after toluene cessation, regions of complete metabolic recovery were the thalamus and cerebellum; however, the temporal cortex did not recover.
CONCLUSIONS: Brain uptake of (18)FDG appears to be a useful tool for examining the metabolic impact of toluene abuse, which include a profound decline followed by region-specific recovery after cessation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16703400     DOI: 10.1007/s00213-006-0359-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  42 in total

1.  Central nervous system effects of chronic toluene abuse--clinical, brainstem evoked response and magnetic resonance imaging studies.

Authors:  N L Rosenberg; M C Spitz; C M Filley; K A Davis; H H Schaumburg
Journal:  Neurotoxicol Teratol       Date:  1988 Sep-Oct       Impact factor: 3.763

2.  Effects of single exposure to toluene on shock avoidance and time estimation in rats.

Authors:  H Wada; T Hosokawa; K Saito
Journal:  Neurobehav Toxicol Teratol       Date:  1986 Nov-Dec

3.  A template for spatial normalisation of MR images of the rat brain.

Authors:  Petra Schweinhardt; Peter Fransson; Lars Olson; Christian Spenger; Jesper L R Andersson
Journal:  J Neurosci Methods       Date:  2003-10-30       Impact factor: 2.390

4.  Solvent abuse-related toluene leukoencephalopathy.

Authors:  Luis Fornazzari; Michael S Pollanen; Vicki Myers; Amparo Wolf
Journal:  J Clin Forensic Med       Date:  2003-06

5.  Toluene inhibits synaptic transmission without causing gross morphological disturbances.

Authors:  Y Ikeuchi; H Hirai
Journal:  Brain Res       Date:  1994-11-21       Impact factor: 3.252

6.  Tolerance and reverse tolerance to toluene inhalation: effects on open-field behavior.

Authors:  D J Himnan
Journal:  Pharmacol Biochem Behav       Date:  1984-10       Impact factor: 3.533

7.  Evaluation of anesthesia effects on [18F]FDG uptake in mouse brain and heart using small animal PET.

Authors:  Hiroshi Toyama; Masanori Ichise; Jeih-San Liow; Douglass C Vines; Nicholas M Seneca; Kendra J Modell; Jurgen Seidel; Michael V Green; Robert B Innis
Journal:  Nucl Med Biol       Date:  2004-02       Impact factor: 2.408

8.  Local cerebral glucose uptake in awake and halothane-anesthetized primates.

Authors:  H M Shapiro; J H Greenberg; M Reivich; G Ashmead; L Sokoloff
Journal:  Anesthesiology       Date:  1978-02       Impact factor: 7.892

Review 9.  The effects of toluene on the central nervous system.

Authors:  Christopher M Filley; William Halliday; B K Kleinschmidt-DeMasters
Journal:  J Neuropathol Exp Neurol       Date:  2004-01       Impact factor: 3.685

10.  Neurologic sequelae of chronic solvent vapor abuse.

Authors:  J T Hormes; C M Filley; N L Rosenberg
Journal:  Neurology       Date:  1986-05       Impact factor: 9.910

View more
  4 in total

1.  Review of toluene action: clinical evidence, animal studies and molecular targets.

Authors:  Silvia L Cruz; María Teresa Rivera-García; John J Woodward
Journal:  J Drug Alcohol Res       Date:  2014

2.  White-matter abnormalities in adolescents with long-term inhalant and cannabis use: a diffusion magnetic resonance imaging study.

Authors:  Murat Yücel; Andrew Zalesky; Michael J Takagi; Emre Bora; Alex Fornito; Michael Ditchfield; Gary F Egan; Christos Pantelis; Dan I Lubman
Journal:  J Psychiatry Neurosci       Date:  2010-11       Impact factor: 6.186

3.  A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator.

Authors:  Martine M Mirrione; Wynne K Schiffer; Joanna S Fowler; Dave L Alexoff; Stephen L Dewey; Stella E Tsirka
Journal:  Neuroimage       Date:  2007-07-18       Impact factor: 6.556

4.  Prenatal exposure to methylphenidate affects the dopamine system and the reactivity to natural reward in adulthood in rats.

Authors:  François-Xavier Lepelletier; Clovis Tauber; Céline Nicolas; Marcello Solinas; Pierre Castelnau; Catherine Belzung; Patrick Emond; Samuele Cortese; Stephen V Faraone; Sylvie Chalon; Laurent Galineau
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.